Evolent Health director reports zero beneficial share ownership

Evolent Health, Inc. reported an initial insider ownership filing for one of its directors.

Rhea-AI Filing Summary

Evolent Health, Inc. reported an initial insider ownership filing for one of its directors. The filing states that as of the event date of December 2, 2025, the reporting person, serving in the role of director, does not beneficially own any shares of Evolent Health common stock or other non-derivative securities. The filing also shows no derivative securities, such as options or warrants, reported as beneficially owned. The document is signed by an attorney-in-fact under a power of attorney dated December 4, 2025, indicating the director’s ownership status is formally recorded as zero at this time.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Smith Jill D.

Role Director

Type	Security	Shares	Price	Value
holding	No securities beneficially owned	--	--	--

Holdings After Transaction: No securities beneficially owned — 0 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this insider filing disclose for Evolent Health (EVH)?

It discloses that a reporting person who is a director of Evolent Health, Inc. has filed an initial ownership statement showing no securities beneficially owned as of the event date.

What is the relationship of the reporting person to Evolent Health (EVH)?

The reporting person is identified as a director of Evolent Health, Inc., with that box checked on the form and no other roles selected.

How many Evolent Health (EVH) shares does the reporting person beneficially own?

The filing states in Table I that there are no securities beneficially owned and lists the amount of securities beneficially owned as 0.

Are there any derivative securities reported for the Evolent Health (EVH) director?

No. Table II, which covers derivative securities such as options or warrants, does not list any positions for the reporting person.

What is the event date referenced in this Evolent Health (EVH) insider report?

The event requiring the statement is dated December 2, 2025, which is the reference date for the ownership disclosure.

Who signed the Evolent Health (EVH) insider ownership form?

The form is signed "/s/ Jonathan Weinberg, Attorney-in-fact", indicating it was executed under a power of attorney on behalf of the reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/12/2025 - 04:11 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Smith Jill D.

(Last) (First) (Middle)

C/O EVOLENT HEALTH, INC.

1812 N. MOORE ST., STE. 1705

(Street)

ARLINGTON VA 22209

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/02/2025

3. Issuer Name and Ticker or Trading Symbol
Evolent Health, Inc. [ EVH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
No securities beneficially owned	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

See Exhibit 24.1 - Power of Attorney dated December 4, 2025.

	/s/ Jonathan Weinberg, Attorney-in-fact	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.